Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"The Effects of Synastol TC (Standardized Terminalia Chebula Fruit Extract) on the Gut Microbiome and Skin Biophysical Properties"

NCT04597502 is registered in ClinicalTrials.gov with Integrative Skin Science and Research as lead sponsor.

NCT NCT04597502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04597502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"The Effects of Synastol TC (Standardized Terminalia Chebula Fruit Extract) on the Gut Microbiome and Skin Biophysical Properties"
Lead sponsor
Integrative Skin Science and Research
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
September 1, 2022
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human microbiome